DafinchiRoper Technologies Raises 2026 EPS Guidance Based on Q1 Outperformance
Roper Technologies raises its full-year 2026 EPS guidance following strong Q1 results and share repurchase impacts, maintaining its revenue growth outlook.
Read post
Detailed company information
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
Last Updated: Sep 2026
Earnings Transcript for 2026 - Q2Released: Aug 05, 2026
Earnings Transcript for 2026 - Q1Released: Apr 28, 2026
Earnings Transcript for 2025 - Q4Released: Feb 10, 2026
Earnings Transcript for 2025 - Q3Released: Nov 05, 2025
Earnings Transcript for 2025 - Q2Released: Aug 07, 2025
Earnings Transcript for 2025 - Q1Released: May 05, 2025
Earnings Transcript for 2024 - Q4Released: Feb 06, 2025
Earnings Transcript for 2024 - Q3Released: Oct 30, 2024
Earnings Transcript for 2024 - Q2Released: Aug 07, 2024
Earnings Transcript for 2024 - Q1Released: May 02, 2024
Earnings Transcript for 2023 - Q4Released: Feb 08, 2024
Earnings Transcript for 2023 - Q3Released: Nov 07, 2023
Earnings Transcript for 2023 - Q2Released: Aug 01, 2023
Earnings Transcript for 2023 - Q1Released: May 02, 2023
Earnings Transcript for 2022 - Q4Released: Feb 03, 2023
Earnings Transcript for 2022 - Q3Released: Nov 02, 2022
Earnings Transcript for 2022 - Q2Released: Aug 02, 2022
Earnings Transcript for 2022 - Q1Released: May 03, 2022
Earnings Transcript for 2021 - Q4Released: Feb 07, 2022
Earnings Transcript for 2021 - Q3Released: Nov 04, 2021
Earnings Transcript for 2021 - Q2Released: Aug 03, 2021
Earnings Transcript for 2020 - Q4Released: Feb 05, 2021
Earnings Transcript for 2020 - Q3Released: Nov 06, 2020
Earnings Transcript for 2020 - Q2Released: Aug 04, 2020
LUNG Pulmonx Corporation
OFIX Orthofix Medical Inc.
GKOS Glaukos Corporation
ITGR Integer Holdings Corporation
CNMD CONMED Corporation
BRKR Bruker Corporation
BIO Bio-Rad Laboratories, Inc.
EW Edwards Lifesciences Corporation
BSX Boston Scientific Corporation
SYK Stryker Corporation
MDT Medtronic plc
ABT Abbott Laboratories
Roper Technologies raises its full-year 2026 EPS guidance following strong Q1 results and share repurchase impacts, maintaining its revenue growth outlook.
Read postZimmer Biomet's Q1 2026 earnings report highlights an upward revision of the company's full-year guidance, reflecting strong Q1 performance and strategic share buybacks.
Read postZimmer Biomet's Q1 2026 performance demonstrates solid organic sales growth and a significant EPS increase, driven by tariff benefits and operational improvements. The company has raised its full-year EPS and cash flow forecasts while maintaining revenue guidance, reflecting confidence in earnings stability.
Read postZimmer Biomet's Q1 2026 results show steady sales growth and significant EPS improvement, prompting a positive outlook update that emphasizes profitability and cash flow advancements.
Read post